IMPACT : Issue 13

Content: - I am a hero! - The hero - Enjoy the colors of life: a party for children with cancer - Events - Our Membershttps://ecommons.aku.edu/impact/1012/thumbnail.jp

IMPACT : Issue 12

Content: - From the Leadership - Hear his Plea - Hepatitis B and C : The Silent Killer - With Gratitude to our Partners and Supportershttps://ecommons.aku.edu/impact/1010/thumbnail.jp

IMPACT : Issue 10

Content - Chairman\u27s Message - Look at the Difference We Made in 2016 - Straight From the Press : The Year in Images - The Change of Kindnesshttps://ecommons.aku.edu/impact/1009/thumbnail.jp

IMPACT : Issue 5

Content - Chairman\u27s Message - During 2014 Your Donations Helped Countless Patients - You Never Walk Alone - Hepatitis : The Silent Killer - First Successful Surgery To Separate Conjoined Twins - With Gratitude To Our Benefactors and Partnershttps://ecommons.aku.edu/impact/1004/thumbnail.jp

IMPACT : Issue 2

Content - Update From The Chairman’s Desk - The Difference We Made in 2012 - Assisting in a Miracle - By Helping Another, Our Own Burden Is Lightened : Mrs Talat Dehlavi - All I Want is to Go Back to School - We Give Zakat Purely to Please Allah : S.M. Muneerhttps://ecommons.aku.edu/impact/1001/thumbnail.jp

IMPACT : Issue 6

Content - Chairman\u27s Message - Light Upon Light - Mending Hearts - APPNA: “It is all about service and giving back.” - “The Aga Khan University is a blessing in this country - S.M. Pervezhttps://ecommons.aku.edu/impact/1005/thumbnail.jp

IMPACT : Issue 4

Content - Chairman’s Message - Distribution of Patients Assisted by PBS - Where There is Life There is Hope : Shaukat Qasim Agaria - Happenings - Dean, Medical College Comes on Board - Department of Oncology - Advancement, innovation and quality : Interview with Mr Moin Fuddahttps://ecommons.aku.edu/impact/1003/thumbnail.jp

Beta-blokers in patients with cirrhosis and infection: don't blame too soon.

We found that PPI-users had a higher rate and BBs-users a lower rate of infections. The lower infection rate and better prognosis of BB-users can not be attributed, as suggested by Schiavon et al., to a higher proportion of variceal bleeding in this group; in fact, the large majority of patients hospitalized for bleeding were excluded from the study as they came to our ward already on systemic antibiotic treatment (which is usually started in the Emergency room) and this would have represented a confounding factor. Only few patients with variceal bleeding were included: they developed bleeding after enrolment and were equally distributed between those taking and not taking BBs. Following the recent debate about the ‘therapeutic window’ of BBs in cirrhotic patients (2–4), we were also interested in evaluating possible harmful effects of BBs in cirrhotic patients with infections. This was a secondary aim of our study and we certainly recognize that the study was underpowered for this purpose